HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Greens Petition German Parliament For OTC COVID-19 Antibody Self Tests

Executive Summary

Commercial COVID-19 antibody self-tests are back on the agenda in Europe, this time in Germany, where the Greens are calling for amendments to the country's medical devices regulations to allow tests to be sold OTC in pharmacies and incentives for industry to quickly scale up production. 

You may also be interested in...



Latest Home-Use COVID-19 Sample Collection Kit Authorized In US Is First Available OTC

Pixel kit allows users to send nasal swab samples to be tested with LabCorp’s a real-time reverse transcription polymerase chain reaction test. Health care providers will call consumers who test positive;  negative test results will be delivered by email or through LabCorp’s online portal.

Prestige Expands UK Eye Care Range In Response To Consumer Demand

A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.

‘Meaningful Revenues’ In 2023 Mark Strategic Milestone As Futura Looks To Future

Futura recorded its first notable revenues last year, generated by the launch of its Eroxon erectile dysfunction gel in the UK and Europe, marking the company's transition from an R&D startup to a consumer healthcare player in its own right. To mark the occasion, CEO James Barder outlines a new strategy, with a focus on innovation in sexual wellness, further global partnerships and sustained profitability. 

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150880

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel